Anebulo Pharmaceuticals Inc (ANEB)
1.59
+0.09
(+6.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.59
0.00 (0.00%)
After-Hours: 18:17
Anebulo Pharmaceuticals Price: 1.59 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 1.25 | 1.68 | 1.25 | 1.50 | 13895.00 |
| Nov 20, 2024 | 1.609 | 1.66 | 1.51 | 1.52 | 3718.00 |
| Nov 19, 2024 | 1.554 | 1.57 | 1.52 | 1.52 | 1849.00 |
| Nov 18, 2024 | 1.53 | 1.53 | 1.53 | 1.53 | 487.00 |
| Nov 15, 2024 | 1.546 | 1.588 | 1.52 | 1.588 | 2443.00 |
| Nov 14, 2024 | 1.65 | 1.730 | 1.52 | 1.52 | 2593.00 |
| Nov 13, 2024 | 1.52 | 1.578 | 1.52 | 1.55 | 4314.00 |
| Nov 12, 2024 | 1.65 | 1.70 | 1.57 | 1.65 | 5454.00 |
| Nov 11, 2024 | 1.632 | 1.69 | 1.62 | 1.69 | 4268.00 |
| Nov 08, 2024 | 1.50 | 1.72 | 1.50 | 1.63 | 9034.00 |
| Nov 07, 2024 | 1.85 | 1.95 | 1.46 | 1.470 | 46609.00 |
| Nov 06, 2024 | 1.823 | 1.87 | 1.82 | 1.87 | 3200.00 |
| Nov 05, 2024 | 1.84 | 1.92 | 1.83 | 1.84 | 5088.00 |
| Nov 04, 2024 | 1.89 | 1.89 | 1.89 | 1.89 | 971.00 |
| Nov 01, 2024 | 1.84 | 1.84 | 1.84 | 1.84 | 587.00 |
| Oct 31, 2024 | 1.85 | 1.904 | 1.830 | 1.88 | 8764.00 |
| Oct 30, 2024 | 1.85 | 1.85 | 1.85 | 1.85 | 270.00 |
| Oct 29, 2024 | 1.85 | 1.895 | 1.84 | 1.895 | 1331.00 |
| Oct 28, 2024 | 1.83 | 1.83 | 1.83 | 1.83 | 410.00 |
| Oct 25, 2024 | 1.87 | 2.00 | 1.83 | 1.83 | 11250.00 |
| Oct 24, 2024 | 1.956 | 1.956 | 1.90 | 1.90 | 601.00 |
| Oct 23, 2024 | 1.89 | 1.89 | 1.89 | 1.89 | 240.00 |
| Oct 22, 2024 | 1.84 | 1.840 | 1.84 | 1.840 | 1388.00 |
| Oct 21, 2024 | 1.85 | 1.933 | 1.85 | 1.86 | 789.00 |
| Oct 18, 2024 | 1.961 | 1.961 | 1.961 | 1.961 | 468.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.470
Minimum
Nov 07 2024
8.95
Maximum
May 21 2021
3.810
Average
2.895
Median
Price Benchmarks
| Revance Therapeutics Inc | 3.725 |
| NovaBay Pharmaceuticals Inc | 0.6855 |
| Palatin Technologies Inc | 0.9589 |
| iBio Inc | 2.64 |
| Theriva Biologics Inc | 1.29 |
Price Related Metrics
| Price to Book Value | 21.72 |
| Earnings Yield | -18.87% |
| Market Cap | 41.23M |